Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Staar Surgical (STAA – Research Report) and Elanco Animal Health (ELAN – Research Report).
Staar Surgical (STAA)
In a report issued on January 9, Thomas Stephan from Stifel Nicolaus maintained a Hold rating on Staar Surgical, with a price target of $30.00. The company’s shares closed last Wednesday at $33.32, close to its 52-week low of $27.00.
According to TipRanks.com, Stephan is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Staar Surgical with a $42.17 average price target, implying a 23.3% upside from current levels. In a report issued on January 8, Needham also maintained a Hold rating on the stock.
See the top stocks recommended by analysts >>
Elanco Animal Health (ELAN)
Stifel Nicolaus analyst Jonathan Block upgraded Elanco Animal Health to Buy on January 9 and set a price target of $20.00. The company’s shares closed last Wednesday at $15.21, close to its 52-week high of $15.94.
According to TipRanks.com, Block is a 4-star analyst with an average return of
Elanco Animal Health has an analyst consensus of Moderate Buy, with a price target consensus of $15.50, representing a 0.5% upside. In a report issued on January 5, Barclays also maintained a Buy rating on the stock with a $18.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on STAA:
- Fly Insider: Athira Pharma, Microstrategy among week’s notable insider trades
- Staar Surgical sees FY24 revenue $335M -$340M, consensus $366.8M
- Staar Surgical sees FY23 revenue $322.5M , consensus $320.5M
- Staar Surgical sees Q4 revenue $76.5M, consensus $74.23M
- Insider Trading: Staar Surgical Stock (NASDAQ:STAA) Gained After $6.5M Insider Purchase
